Baseline serum syndecan-4 predicts prognosis after the onset of acute exacerbation of idiopathic interstitial pneumonia.

MLA

Sato, Yuki, et al. “Baseline Serum Syndecan-4 Predicts Prognosis after the Onset of Acute Exacerbation of Idiopathic Interstitial Pneumonia.” PloS One, vol. 12, no. 5, May 2017, p. e0176789. EBSCOhost, https://doi.org/10.1371/journal.pone.0176789.

APA

Sato, Y., Tanino, Y., Wang, X., Nikaido, T., Sato, S., Misa, K., Togawa, R., Frevert, C. W., & Munakata, M. (2017). Baseline serum syndecan-4 predicts prognosis after the onset of acute exacerbation of idiopathic interstitial pneumonia. PloS One, 12(5), e0176789. https://doi.org/10.1371/journal.pone.0176789

Chicago

Sato, Yuki, Yoshinori Tanino, Xintao Wang, Takefumi Nikaido, Suguru Sato, Kenichi Misa, Ryuichi Togawa, Charles W Frevert, and Mitsuru Munakata. 2017. “Baseline Serum Syndecan-4 Predicts Prognosis after the Onset of Acute Exacerbation of Idiopathic Interstitial Pneumonia.” PloS One 12 (5): e0176789. doi:10.1371/journal.pone.0176789.